Back to search

Article

Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals

2021-10-18

Abstract excerpt

<h4>Background</h4> To determine the kinetics and persistence of immune responses following the Sinopharm/BBIBP-CorV, we investigated immune responses in a cohort of Sri Lankan individuals. <h4>Methods</h4> SARS-CoV-2 specific total antibodies were measured in 20-to-39 year (n=61), 40-to-59-year and those >60 years of age (n=22) by ELISA, 12 weeks after the second dose of the vaccine. ACE2 receptor blocking antibo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
69d83abd-63c6-5dd8-9fbd-7d745c6a8ce8
DOI
10.1101/2021.10.14.21265030
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individualsDOI 10.1101/2021.10.14.21265030
Comparison of kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222Semantic proximity
Changes in population immunity to omicron SARS-CoV-2 variants and selected Sarbecoviruses from 2020 to 2023 in urban Colombo, Sri LankaSemantic proximity
Comparison of the Immunogenicity of five COVID-19 vaccines in Sri LankaSemantic proximity
Differential Adaptive Immune Responses Following SARS-CoV-2 Infection in Children Compared to AdultsSemantic proximity
Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19Semantic proximity
Virus neutralizing antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccineSemantic proximity
Humoral immunity to endemic coronaviruses in older adults increases post-COVID-19 vaccination and in correlation with their anti-SARS-CoV-2 responsesSemantic proximity
The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New ZealandSemantic proximity
Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccinesSemantic proximity
Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infectionSemantic proximity
Long-term immune persistence induced by two-dose BBIBP-CorV vaccine with different intervals, and immunogenicity and safety of a homologous booster dose in high-risk occupational population. Secondary Study Based on a Randomized Clinical TrialSemantic proximity
Select a neighboring publication to make it the new centre.